Company intelligence / Profile preview

VieCure

Denver, Colorado, United States

Ownership: Private
Development stage: Other

Overview

VieCure delivers the Halo Intelligence platform, a commercially available AI-enabled clinical decision support and smart electronic medical record (EMR) system tailored for community oncology care. It is used to manage over 18,000 patients daily across more than 100 sites, supporting personalized cancer treatment options and improving operational efficiency, with no published clinical trial outcome data but widespread clinical adoption and evidence-based design.[1][2][3]

Therapeutic areas: Oncology
Industry: Digital Health Medical Devices

Partnerships

Guardant Health (NGS and liquid biopsy/genomic test integration)[3]National Comprehensive Cancer Network (non-exclusive licensing for NCCN Chemotherapy Order Templates)[2]

Beyond the preview

Go deeper on VieCure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VieCure.

Explore the full profile